search
Back to results

Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs)

Primary Purpose

HIV, Hepatitis C

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Motivational interviewing
Educational intervention
Sponsored by
Université de Sherbrooke
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for HIV focused on measuring Vulnerable Populations, Injecting drug users, IDU, Risky injecting practices, Psychotherapy, brief, Motivational interviewing, Educational activities, Clinical trial, Risk behavior, risk reduction behavior

Eligibility Criteria

16 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • In the last month, at least one cocaine injection
  • In the last month, at least one injection with a syringe or another piece of injection equipment that has been used by someone else
  • 16 years old or more
  • French speaking
  • Being able to give informed consent

Sites / Locations

  • Université de Sherbrooke, service de toxicomanie (Campus Longueuil)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Motivational interviewing

Educational intervention

Arm Description

Motivational interviewing is a client-centered, directive method for enhancing intrinsic motivation to change by exploring and resolving ambivalence (Miller & Rollnick. 1993). This 45 minutes individual motivational intervention focuses on risky injection practices.

The educational intervention is a 45 minutes individual intervention based on a document written by the Québec ministry of health (Québec, Canada). The aim is to inform participants about safe injection practices and to show them how to use sterile injection equipment.

Outcomes

Primary Outcome Measures

Risky injecting practices

Secondary Outcome Measures

Stages of change for risky injecting practices (adapted from Prochaska & DiClemente)
Drug use (including injecting frequency)

Full Information

First Posted
November 19, 2008
Last Updated
April 2, 2014
Sponsor
Université de Sherbrooke
Collaborators
Fonds de la Recherche en Santé du Québec
search

1. Study Identification

Unique Protocol Identification Number
NCT00794391
Brief Title
Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs)
Official Title
Effects of a Brief Motivational Intervention on Risky Injection Practices Among Injecting Drug Users
Study Type
Interventional

2. Study Status

Record Verification Date
April 2014
Overall Recruitment Status
Completed
Study Start Date
November 2008 (undefined)
Primary Completion Date
August 2011 (Actual)
Study Completion Date
August 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Université de Sherbrooke
Collaborators
Fonds de la Recherche en Santé du Québec

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the effects of a brief motivational intervention in reducing risky injection practices among injecting drug users (IDUs). The investigators hypothesis is that motivational intervention will be more effective than educational intervention in reducing risky injection practices among IDUs.
Detailed Description
Injecting drug users (IDUs) are among the most vulnerable populations at risk to contract human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Among Canadian cities, Montreal holds one of the higher HIV and HCV contraction rates in the IDU population. Results from SurvUDI, a population survey among IDUs conducted in the province of Quebec (Canada), show that in Montreal 18% of IDUs are infected with HIV and 67% are infected with HCV. The cornerstone of HIV and HCV prevention strategies is to give information on safe injection practices and to make available sterile syringes and other injection equipment. However, the SurvUDI survey reveals that a large proportion of IDUs recruited in community programs offering sterile injection equipment and information on safe injection practices are still sharing needles with other IDUs. Indeed, it seems that information dissemination and distribution of sterile injection equipment are not sufficient in order to control the HIV and HCV epidemic among IDUs. As a matter of fact, it is obvious that complementary interventions such as behavioural interventions are required. Motivational interviewing is an intervention technique centered on the individual. It aims to enhance intrinsic motivation to change behavior by helping the individual to resolve ambivalence. The scientific literature indicates that brief motivational intervention is a significantly effective intervention in order to reduce drug use problems and other related health problems. Furthermore, motivational intervention is well adapted for IDUs' resistance to change and their difficulties related with involvement in long-term therapeutic process. The present study's hypothesis is that IDUs assigned to the experimental group (brief motivational intervention) will present a greater diminution of their risky injection practices in comparison with IDUs assigned to the control group (educational intervention).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV, Hepatitis C
Keywords
Vulnerable Populations, Injecting drug users, IDU, Risky injecting practices, Psychotherapy, brief, Motivational interviewing, Educational activities, Clinical trial, Risk behavior, risk reduction behavior

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
219 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Motivational interviewing
Arm Type
Experimental
Arm Description
Motivational interviewing is a client-centered, directive method for enhancing intrinsic motivation to change by exploring and resolving ambivalence (Miller & Rollnick. 1993). This 45 minutes individual motivational intervention focuses on risky injection practices.
Arm Title
Educational intervention
Arm Type
Active Comparator
Arm Description
The educational intervention is a 45 minutes individual intervention based on a document written by the Québec ministry of health (Québec, Canada). The aim is to inform participants about safe injection practices and to show them how to use sterile injection equipment.
Intervention Type
Behavioral
Intervention Name(s)
Motivational interviewing
Intervention Description
Motivational interviewing is a client-centered, directive method for enhancing intrinsic motivation to change by exploring and resolving ambivalence (Miller & Rollnick. 1993). This 45 minutes individual motivational intervention focuses on risky injection practices.
Intervention Type
Behavioral
Intervention Name(s)
Educational intervention
Intervention Description
The educational intervention is a 45 minutes individual intervention based on a document written by the Québec ministry of health (Québec, Canada). The aim is to inform participants about safe injection practices and to show them how to use sterile injection equipment.
Primary Outcome Measure Information:
Title
Risky injecting practices
Time Frame
3 and 6 month follow-ups
Secondary Outcome Measure Information:
Title
Stages of change for risky injecting practices (adapted from Prochaska & DiClemente)
Time Frame
3 and 6 month follow-ups
Title
Drug use (including injecting frequency)
Time Frame
3 and 6 months follow-ups

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: In the last month, at least one cocaine injection In the last month, at least one injection with a syringe or another piece of injection equipment that has been used by someone else 16 years old or more French speaking Being able to give informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karine Bertrand, Ph.D.
Organizational Affiliation
Université de Sherbrooke
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Élise Roy, MD, MSc
Organizational Affiliation
Université de Sherbrooke
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Carole Morissette, MD, FRCPC
Organizational Affiliation
Université de Montréal & Direction de santé publique de Montréal
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Jean-François Boivin, MD, FRCPC
Organizational Affiliation
McGill University
Official's Role
Study Chair
Facility Information:
Facility Name
Université de Sherbrooke, service de toxicomanie (Campus Longueuil)
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H2L 1Y8
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs)

We'll reach out to this number within 24 hrs